Cargando…

Combination radioimmunotherapy with adoptive NK transfer targets cancer stem cells in canine models of bone and soft tissue sarcoma

Detalles Bibliográficos
Autores principales:	Canter, Robert, Grossenbacher, Steven K, Park, Jiwon Sarah, Modiano, Jaime, Ames, Erik, Mac, Stephanie, Monjazeb, Arta M, Kent, Michael, Culp, William, Chen, Mingyi, Murphy, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645235/ http://dx.doi.org/10.1186/2051-1426-3-S2-P4

Ejemplares similares

Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial
por: Canter, Robert J., et al.
Publicado: (2017)

Canine cancer immunotherapy studies: linking mouse and human
por: Park, Jiwon S., et al.
Publicado: (2016)

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma
por: Canter, Robert J, et al.
Publicado: (2014)

Combined radiotherapy and immunotherapy using CPG oligodeoxynucleotides and indolamine 2,3 dioxygenase (IDO) blockade
por: Monjazeb, Arta M, et al.
Publicado: (2013)

Enhanced natural killer cell targeting of cancer stem cells using Cetuximab
por: Grossenbacher, Steven K, et al.
Publicado: (2014)

Blocking indolamine 2,3 dioxygenase mediated rebound immune suppression improves systemic anti-tumor effects of radio-immunotherapy
por: Monjazeb, Arta M, et al.
Publicado: (2015)

Transcriptome Analysis of Tumor-Infiltrating Lymphocytes Identifies NK Cell Gene Signatures Associated With Lymphocyte Infiltration and Survival in Soft Tissue Sarcomas
por: Judge, Sean J., et al.
Publicado: (2022)

Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity
por: Grossenbacher, Steven, et al.
Publicado: (2015)

Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas
por: Judge, Sean J, et al.
Publicado: (2020)

Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer
por: Judge, Sean J., et al.
Publicado: (2020)

Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
por: Monjazeb, Arta Monir, et al.
Publicado: (2013)

Head and Neck Cutaneous Soft-Tissue Sarcoma Demonstrate Sex and Racial/Ethnic Disparities in Incidence and Socioeconomic Disparities in Survival
por: Jawad, Muhammad Umar, et al.
Publicado: (2022)

Intratumoral NKp46(+) natural killer cells are spatially distanced from T and MHC-I(+) cells with prognostic implications in soft tissue sarcoma
por: Cruz, Sylvia M., et al.
Publicado: (2023)

Missing a “Missing Self” Mechanism: Modeling and Detection of Ly49 Expression in Canine NK Cells
por: Gingrich, Alicia A., et al.
Publicado: (2023)

Role of Radiation Therapy in Adult Extraskeletal Ewing's Sarcoma Patients Treated with Chemotherapy and Surgery
por: Saiz, Augustine M., et al.
Publicado: (2019)

Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis
por: Perry, Lauren M, et al.
Publicado: (2023)

Natural killer cell immunotherapy to target stem-like tumor cells
por: Grossenbacher, Steven K., et al.
Publicado: (2016)

Natural Killer and T Cell Infiltration in Canine Osteosarcoma: Clinical Implications and Translational Relevance
por: Razmara, Aryana M., et al.
Publicado: (2021)

Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction
por: Ménager, Jérémie, et al.
Publicado: (2015)

Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells
por: Grossenbacher, Steven K, et al.
Publicado: (2013)

Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence
por: Judge, Sean J., et al.
Publicado: (2020)

A possible new pathway in natural killer cell activation also reveals the difficulty in determining human NK cell function in cancer
por: Canter, Robert J., et al.
Publicado: (2018)

Pretargeted Molecular Imaging and Radioimmunotherapy
por: Goldenberg, David M., et al.
Publicado: (2012)

T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
por: Sparger, Ellen E., et al.
Publicado: (2021)

Delayed phlegmon with gallstone fragments masquerading as soft tissue sarcoma
por: Goodman, Laura F., et al.
Publicado: (2016)

Using the canine microbiome to bridge translation of cancer immunotherapy from pre-clinical murine models to human clinical trials
por: Kleber, Kara T., et al.
Publicado: (2022)

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target
por: Sabanathan, Dhanusha, et al.
Publicado: (2021)

Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells
por: Luna, Jesus I., et al.
Publicado: (2019)

Immunostimulatory effects of radioimmunotherapy
por: Constanzo, Julie, et al.
Publicado: (2022)

Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models
por: Broqueza, Jaline, et al.
Publicado: (2021)

Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy
por: Gingrich, Alicia A., et al.
Publicado: (2019)

Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
por: Kisseberth, William C., et al.
Publicado: (2021)

Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+ T Cell Help
por: Monjazeb, Arta M., et al.
Publicado: (2014)

Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
por: Gentschev, Ivaylo, et al.
Publicado: (2012)

Mouse Preclinical Cancer Immunotherapy Modeling Involving Anti-PD-1 Therapies Reveals the Need to Use Mouse Reagents to Mirror Clinical Paradigms
por: Monjazeb, Arta M., et al.
Publicado: (2021)

Radioimmunotherapy: a brief overview
por: Ng, DCE
Publicado: (2006)

Is radioimmunotherapy a 'magic bullet'?
por: Kim, Sung-Hyun
Publicado: (2012)

Improvement of Radioimmunotherapy Using Pretargeting
por: Frampas, Eric, et al.
Publicado: (2013)

Trial Watch: Anticancer radioimmunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Radiographic and Histologic Response to Neoadjuvant Radiotherapy in Patients With Soft Tissue Sarcoma
por: Canter, Robert J., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kg0tjkssiubverijhs7v6au1ld